Table 2.
Results of Univariate and Multivariate Linear Regression Analyses Assessing Associations Between Serum Uric Acid Concentrations at Baseline and the PEP/ET Ratio, NT-proBNP Concentrations, and the baPWV Measured at Baseline and at the End of the Study Period
| Outcome variable | Crude | AdjustedA | ||||||
|---|---|---|---|---|---|---|---|---|
| Total R2
(×10−1) |
Standardized coefficient (×10−1) |
Non-standardized coefficient (×10−1; 95% CI) |
P value | Total R2
(×10−1) |
Standardized coefficient (×10−1) |
Non-standardized coefficient (×10−1; 95% CI) |
P value | |
| PEP/ET ratio | ||||||||
| At baseline | 0.04 | 0.69 | 0.03 (0.01, 0.04) | <0.01 | 1.4 | 0.73 | 0.03 (0.01, 0.05) | <0.01 |
| At the end of the study | 0.08 | 0.93 | 0.04 (0.02, 0.06) | <0.01 | 1.0 | 0.60 | 0.02 (0.01, 0.04) | 0.01 |
| Log [NT-proBNP] | ||||||||
| At baseline | 0.04 | −0.62 | −0.43 (−0.69, 0.17) | <0.01 | 1.7 | −0.48 | −0.33 (−0.63, 0.03) | 0.03 |
| At the end of the study | −0.05 | −0.08 | −0.05 (−0.33, 0.23) | 0.72 | 0.14 | – | – | 0.53 |
| baPWV | ||||||||
| At baseline | 0.05 | 0.76 | 1.2 (0.6, 1.8) | <0.01 | 4.9 | 0.71 | 1.1 (0.56, 1.6) | <0.01 |
| At the end of the study | 0.1 | 1.0 | 1.7 (1.0, 2.5) | <0.01 | 3.8 | 0.81 | 1.3 (0.72, 2.0) | <0.01 |
AAdjusted for age, BMI, SBP, heart rate, HbA1c, serum LDL-C, current smoking, amount of drinking, and past medical history of hyperuricemia at baseline. CI, confidence interval; [NT-proBNP], serum NT-proBNP concentration. Other abbreviations as in Table 1.